- Investing Ideas
- /
- Japanese Biotech Stocks
Japanese Biotech Stocks
Results
54
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
54 companies
RaQualia Pharma
Market Cap: JP¥7.3b
Engages in the research and development of pharmaceutical compounds worldwide.
4579
JP¥335.00
7D
-5.6%
1Y
-45.4%
Solasia Pharma K.K
Market Cap: JP¥7.0b
Engages in the development and marketing of oncology drugs in Japan and other Asian countries.
4597
JP¥32.00
7D
-3.0%
1Y
10.3%
Linical
Market Cap: JP¥6.5b
Provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide.
2183
JP¥286.00
7D
-7.1%
1Y
-26.5%
OncoTherapy Science
Market Cap: JP¥6.2b
Engages in research and development of anti-body drugs; and the genome analysis of cancer, liquid biopsy, and development of new immunotherapy in Japan.
4564
JP¥23.00
7D
-11.5%
1Y
9.5%
TMS
Market Cap: JP¥6.0b
Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.
4891
JP¥150.00
7D
2.7%
1Y
-41.2%
Noile-Immune Biotech
Market Cap: JP¥5.9b
Researches and develops CAR-T cells for cancer immunotherapies.
4893
JP¥137.00
7D
-11.0%
1Y
-26.7%
Modalis Therapeutics
Market Cap: JP¥5.6b
Engages in the research and development of therapeutics to treat patients with serious genetic disorders.
4883
JP¥76.00
7D
-3.8%
1Y
-17.4%
Kringle Pharma
Market Cap: JP¥5.4b
Engages in the research and development, manufactures, and sells hepatocyte growth factor (HGF) protein pharmaceuticals for regenerative medicines.
4884
JP¥784.00
7D
-6.1%
1Y
34.5%
Nippon Chemiphar
Market Cap: JP¥5.2b
Engages in the manufacture, sale, import, and export of ethical pharmaceuticals and diagnostic agents in Japan and internationally.
4539
JP¥1,449.00
7D
-1.4%
1Y
-11.7%
Precision System Science
Market Cap: JP¥5.2b
Develops, manufactures, and sells automated systems/instruments, other physicochemical instruments, software, and other products.
7707
JP¥189.00
7D
-8.3%
1Y
-5.0%
D. Western Therapeutics Institute
Market Cap: JP¥4.7b
A biotechnology company, focuses on discovery and development of various drugs.
4576
JP¥104.00
7D
-1.0%
1Y
-11.9%
Immuno-Biological Laboratories
Market Cap: JP¥4.1b
Engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide.
4570
JP¥436.00
7D
-3.3%
1Y
-10.7%
Human Metabolome Technologies
Market Cap: JP¥4.0b
Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan.
6090
JP¥675.00
7D
2.7%
1Y
-3.6%
Ribomic
Market Cap: JP¥3.8b
Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan.
4591
JP¥85.00
7D
-6.6%
1Y
-1.2%
FunPep
Market Cap: JP¥3.2b
Engages in the research and development of pharmaceuticals drugs, functional cosmetics, and medical devices based on functional peptides.
4881
JP¥99.00
7D
-6.6%
1Y
-34.0%
Transgenic Group
Market Cap: JP¥2.9b
Develops, distributes, and licenses genetically modified animals and antibodies in Japan.
2342
JP¥177.00
7D
0.6%
1Y
-22.4%
atect
Market Cap: JP¥1.6b
Engages in the sanitation inspection equipment, powder injection molding (PIM), and semiconductor material businesses.
4241
JP¥365.00
7D
-8.3%
1Y
-54.8%
PhoenixBio
Market Cap: JP¥1.3b
Provides contract study services for drug discovery and development primarily in Japan.
6190
JP¥309.00
7D
-8.8%
1Y
-35.5%